The glutamate/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survival.
Stanulović, Vesna S Al Omair, Shorog Reed, Michelle A C Roberts, Jennie Potluri, Sandeep Fulton-Ward, Taylor Gudgeon, Nancy Bishop, Emma L Roels, Juliette Perry, Tracey A
Stanulović, Vesna S
Al Omair, Shorog
Reed, Michelle A C
Roberts, Jennie
Potluri, Sandeep
Fulton-Ward, Taylor
Gudgeon, Nancy
Bishop, Emma L
Roels, Juliette
Perry, Tracey A
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2024-05-30
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is a cancer of the immune system. Approximately 20% of paediatric and 50% of adult T-ALL patients have refractory disease or relapse and die from the disease. To improve patient outcome new therapeutics are needed. With the aim to identify new therapeutic targets, we combined the analysis of T-ALL gene expression and metabolism to identify the metabolic adaptations that T-ALL cells exhibit. We found that glutamine uptake is essential for T-ALL proliferation. Isotope tracing experiments showed that glutamine fuels aspartate synthesis through the TCA cycle and that glutamine and glutamine-derived aspartate together supply three nitrogen atoms in purines and all but one atom in pyrimidine rings. We show that the glutamate-aspartate transporter EAAT1 (SLC1A3), which is normally expressed in the central nervous system, is crucial for glutamine conversion to aspartate and nucleotides and that T-ALL cell proliferation depends on EAAT1 function. Through this work, we identify EAAT1 as a novel therapeutic target for T-ALL treatment.
Citation
Stanulović VS, Al Omair S, Reed MAC, Roberts J, Potluri S, Fulton-Ward T, Gudgeon N, Bishop EL, Roels J, Perry TA, Sarkar S, Pratt G, Taghon T, Dimeloe S, Günther UL, Ludwig C, Hoogenkamp M. The glutamate/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survival. Haematologica. 2024 Nov 1;109(11):3505-3519. doi: 10.3324/haematol.2023.283471.
Type
Article